{"schema_version":"secwatch.filing_event.v1","accession":"0000947871-24-000009","form_type":"8-K","ticker":"CVS","cik":"0000064803","company_name":"CVS HEALTH Corp","filed_at":"2024-01-05T23:59:59+00:00","discovered_at":"2026-05-14T18:03:26.672861+00:00","generated_at":"2026-06-07T03:36:41.715378+00:00","sec_items":["2.02","5.02","7.01","9.01"],"event_type":"leadership","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"CVS names Tom Cowhey CFO, Mike Pykosz President of Health Care Delivery; reaffirms FY2023 and FY2024 guidance","bullets":["Thomas F. Cowhey appointed EVP and CFO effective Jan 5, 2024; receives $1M base salary, target cash incentive 150%, and $5.5M equity award.","Shawn Guertin steps down as CFO and President of Health Services due to family health reasons; will leave CVS on May 31, 2024.","Mike Pykosz appointed President of Health Care Delivery; he was CEO of Oak Street Health and interim lead since Oct 13, 2023.","Reaffirms 2023 GAAP EPS guidance $6.37-$6.61, Adjusted EPS $8.50-$8.70 (expects upper half); 2024 guidance at least $7.26 GAAP, $8.50 Adjusted.","Expects Medicare Advantage membership growth of at least 800k in 2024; enrollment exceeded expectations during annual enrollment."],"urls":{"canonical":"https://secwatch.observer/filing/0000947871-24-000009","json":"https://secwatch.observer/filing/0000947871-24-000009.json","markdown":"https://secwatch.observer/filing/0000947871-24-000009.md","text":"https://secwatch.observer/filing/0000947871-24-000009.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/64803/000094787124000009/0000947871-24-000009-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/64803/000094787124000009/ss2874786_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-07T03:36:41.715378+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"4011969de1","claim":"Thomas F. Cowhey was appointed as Executive Vice President and Chief Financial Officer at CVS HEALTH Corp.","evidence_excerpt":"The Board of Directors (the “Board”) of CVS Health appointed Thomas F. Cowhey to serve as CVS Health’s Executive Vice President and Chief Financial Officer, effective January 5, 2024.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/64803/000094787124000009/0000947871-24-000009-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Executive Vice President and Chief Financial Officer"}],"fact_type":"executive_change"},{"claim_id":"e0a2e7a3c2","claim":"Shawn M. Guertin departed as Executive Vice President, Chief Financial Officer and President of Health Services at CVS HEALTH Corp.","evidence_excerpt":"On January 5, 2024, CVS Health also announced that Shawn M. Guertin, who, as previously disclosed, was on a personal leave of absence since October 13, 2023, will step down from his role as CVS Health’s Executive Vice President, Chief Financial Officer and President of Health Services due to family health reasons, effective immediately.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/64803/000094787124000009/0000947871-24-000009-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"stepped down"},{"label":"Role","value":"Executive Vice President, Chief Financial Officer and President of Health Services"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}